Abstract:The epigenetic memory stored in the dynamic modifications, such as base modifications of cytosine (C) in DNA, including methylation/hydroxymethylation/demethylation, causes heritable phenotypes via regulating gene expression without alteration of DNA sequence. The process from cytosine modification to the epigenetic effect is orchestrated by complicated machinery consisting of writers, erasers, readers, and other factors. The two major forms of cytosine modification include methylcytosine (5-mC) and hydroxymethylcytosine (5-hmC). DNA methyltransferases (DNMTs) including DNMT1, DNMT3A, and DNMT3B function as writers for 5-mC. The ten-eleven translocation proteins (TET) including TET1, TET2, and TET3 in the mammalian genome are responsible for hydroxymethylation of 5-mC to generate 5-hmC, 5-formylcytosine (5-fC), and 5-carboxylcytosine (5-caC). The 5-mC and 5-hmC have become the two most extensively investigated epigenetic markers, and the dynamic balance of these two markers shape the landscape of the epigenome, functioning as a platform to regulate gene expression epigenetically. The landscape of the 5-hmC in epigenome is precisely and tightly regulated during the development. Aberrant alterations of the epigenetic regulation may cause severe consequences such as phenotype change as well as initiation of disease. Progressively, significant achievements have been made in characterization of writers, erasers, and readers of 5-mC and 5-hmC, as well as the contribution of aberrant alteration of 5-hmC/5-mC landscape to the pathogenesis of human diseases, such as cancers and neurological disorders. This article will highlight the research advances in the distinct contribution of TET proteins as suppressors or promoters to the pathogenesis of tumorigenesis and progression. Furthermore, this article also discusses the challenges and the directions for research in the future.

Cytosine Modifications and Distinct Functions of TET1 on Tumorigenesis

Ten-eleven translocation proteins (TETs): tumor suppressors or tumor enhancers?

Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine.

Genome-wide Analysis Reveals TET-and TDG-mediated 5-Methylcytosine Oxidation Dynamics

5-Hydroxymethylcytosine: generation, fate, and genomic distribution.

TET (Ten-eleven translocation) family proteins: structure, biological functions and applications

The Molecular Basis Of Dna Demethylation

Epigenetic Function of TET Family, 5-Methylcytosine, and 5-Hydroxymethylcytosine in Hematologic Malignancies

Role of TET enzymes in DNA methylation, development, and cancer

The emerging insights into catalytic or non-catalytic roles of TET proteins in tumors and neural development

Multiple Functions of Ten-eleven Translocation 1 During Tumorigenesis.

Tet2 Activity is Modulated by Sirt1-Mediated Protein Deacetylation: A Potential Therapeutic Target in Myelodysplastic Syndrome

Insights into the Biochemistry, Evolution, and Biotechnological Applications of the Ten-Eleven Translocation (TET) Enzymes

Advances in RNA Cytosine-5 Methylation: Detection, Regulatory Mechanisms, Biological Functions and Links to Cancer

Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma

Tet1 Regulates Dna Replication Through Targeting of Minichromosome Maintenance Genes

TET-Mediated Epigenetic Regulation in Immune Cell Development and Disease

Ten-Eleven-Translocation Genes in Cancer.

MBD3L2 promotes Tet2 enzymatic activity for mediating 5-methylcytosine oxidation.

Ten-eleven Translocation-2 Affects the Fate of Cells and Has Therapeutic Potential in Digestive Tumors

Structure and Function of TET Enzymes